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The enterprise value evaluation is the foundation of the enterprise value 
management. The evaluation regards enterprise as a organic entity; it brings a 
comprehensive estimate of the market value on the basis of the factors which affect 
the profitability and the conditions of all assets. Fosunpharma has been one listed 
pharmaceutical company for years, it owns business like pharmacy, research and 
development, medicine distribution, medical service; meanwhile owns a plenty of 
equity asset via continual investment. The equity investment has been the major 
method and mode of the development of Fosunpharmar , and constitutes the primary 
business. How to assess the core competence of Fosunpharma? How about the value 
of Fosunpharma? How to evaluate the value of Fosunpharma? This paper provides the 
direction and ideas for the value management of Fosunpharma and brings views for 
the capital market which could understand Fosunpharma better. 
This paper attempts to apply the discounted free cash flow model in evaluating the 
corporation value of Fosunpharma, and modify the value by the market comparison 
approach theory. 
This article is divided into five chapters. The first chapter is the theoretical basis of 
the enterprise value evaluation. It discusses the enterprise value, the influencing factor, 
the definition and the method of enterprise value evaluation, and then brings the 
evaluation framework which is based on the discounted free cash flow model. The 
second chapter analyzes the industrial feature and the influencing factor, and then 
analyzes the competitiveness of the target company. The third chapter analyzes the 
strategic goals and constructs the financial statement. The forth chapter is the key 
chapter. It applied the discounted free cash flow method in calculating the value of the 
target company, and also applied the market comparison approach theory in 
contrasting several companies from public capital market. The fifth chapter is the 
conclusion. It combined the result which is from the two evaluation methods with the 
analysis of the enterprise competitiveness. Then it estimates the cause and rationality 
of the enterprise value proposition. 
This paper is based on the discounted free cash flow model and to analyze and 
evaluate one enterprise which is known to the author; and it would analyze the reason 
why the enterprise value is differentiated with other similar companies. Due to the 














however it is still one helpful viewpoint to the managers who process the value 
management and the investor who want to know the corporation better. 
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